fda warning letter hims compounded semaglutide september 2025 and Hers warns investors about potential liability for FDA-regulated prescription drug ads – Partnership for Safe Medicines The FDA sent a warning

(3) development of next-generation GLP-1 receptor-targeted therapeutics with enhanced specificity and reduced off-target effects [129,130,131,132]

Ozempic Rebound: Most People Regain Weight After Stopping Semaglutide New York Times

PTC samples from 106 pediatric patients (age range: 4.319.8 years

Vials commonly come in 2mL (20mg total tirzepatide) or 4mL (40mg total tirzepatide) sizes, depending on the prescription and dosing needs

Houstons subtropical climate with high humidity and extended heat creates unique physiological considerations

What to ask your doctor Omalizumab is a promising new treatment for seasonal allergies, but the FDA has not specifically approved it for seasonal allergy care yet